0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global EPA DHA ALA (Omega 3) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37X8273
Home | Market Reports | Health| Nutrition
Global EPA DHA ALA Omega 3 Market Insights and Forecast to 2028
BUY CHAPTERS

Global EPA DHA ALA (Omega 3) Market Research Report 2025

Code: QYRE-Auto-37X8273
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

EPA DHA ALA (Omega 3) Market Size

The global market for EPA DHA ALA (Omega 3) was valued at US$ 14350 million in the year 2024 and is projected to reach a revised size of US$ 18360 million by 2031, growing at a CAGR of 3.6% during the forecast period.

EPA DHA ALA (Omega 3) Market

EPA DHA ALA (Omega 3) Market

Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Global Omega-3 main players are DSM, BASF, Marine Ingredients, OLVEA Fish Oils, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 35%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for EPA DHA ALA (Omega 3), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EPA DHA ALA (Omega 3).
The EPA DHA ALA (Omega 3) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global EPA DHA ALA (Omega 3) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EPA DHA ALA (Omega 3) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of EPA DHA ALA (Omega 3) Market Report

Report Metric Details
Report Name EPA DHA ALA (Omega 3) Market
Accounted market size in year US$ 14350 million
Forecasted market size in 2031 US$ 18360 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company EPAX, Golden Omega, TASA, Omega Protein, Croda, KD Pharma, GC Rieber, Polaris, Auqi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of EPA DHA ALA (Omega 3) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of EPA DHA ALA (Omega 3) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is EPA DHA ALA (Omega 3) Market growing?

Ans: The EPA DHA ALA (Omega 3) Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the EPA DHA ALA (Omega 3) Market size in 2031?

Ans: The EPA DHA ALA (Omega 3) Market size in 2031 will be US$ 18360 million.

What is the market share of major companies in EPA DHA ALA (Omega 3) Market?

Ans: Global top four manufacturers hold a share over 40%.

What is the EPA DHA ALA (Omega 3) Market share by region?

Ans: North America is the largest market, with a share nearly 35%.

Who are the main players in the EPA DHA ALA (Omega 3) Market report?

Ans: The main players in the EPA DHA ALA (Omega 3) Market are EPAX, Golden Omega, TASA, Omega Protein, Croda, KD Pharma, GC Rieber, Polaris, Auqi

What are the Application segmentation covered in the EPA DHA ALA (Omega 3) Market report?

Ans: The Applications covered in the EPA DHA ALA (Omega 3) Market report are Dietary Supplements, Functional Foods & Beverages, Others

What are the Type segmentation covered in the EPA DHA ALA (Omega 3) Market report?

Ans: The Types covered in the EPA DHA ALA (Omega 3) Market report are Fish Oil, Algae Oil

Recommended Reports

Omega-3 Ingredients

Fish & Algae Oils

Functional Food Uses

1 EPA DHA ALA (Omega 3) Market Overview
1.1 Product Definition
1.2 EPA DHA ALA (Omega 3) by Type
1.2.1 Global EPA DHA ALA (Omega 3) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 EPA DHA ALA (Omega 3) by Application
1.3.1 Global EPA DHA ALA (Omega 3) Market Value by Application (2024 VS 2031)
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Global EPA DHA ALA (Omega 3) Market Size Estimates and Forecasts
1.4.1 Global EPA DHA ALA (Omega 3) Revenue 2020-2031
1.4.2 Global EPA DHA ALA (Omega 3) Sales 2020-2031
1.4.3 Global EPA DHA ALA (Omega 3) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 EPA DHA ALA (Omega 3) Market Competition by Manufacturers
2.1 Global EPA DHA ALA (Omega 3) Sales Market Share by Manufacturers (2020-2025)
2.2 Global EPA DHA ALA (Omega 3) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global EPA DHA ALA (Omega 3) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of EPA DHA ALA (Omega 3), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of EPA DHA ALA (Omega 3), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of EPA DHA ALA (Omega 3), Product Type & Application
2.7 Global Key Manufacturers of EPA DHA ALA (Omega 3), Date of Enter into This Industry
2.8 Global EPA DHA ALA (Omega 3) Market Competitive Situation and Trends
2.8.1 Global EPA DHA ALA (Omega 3) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest EPA DHA ALA (Omega 3) Players Market Share by Revenue
2.8.3 Global EPA DHA ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global EPA DHA ALA (Omega 3) Market Scenario by Region
3.1 Global EPA DHA ALA (Omega 3) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global EPA DHA ALA (Omega 3) Sales by Region: 2020-2031
3.2.1 Global EPA DHA ALA (Omega 3) Sales by Region: 2020-2025
3.2.2 Global EPA DHA ALA (Omega 3) Sales by Region: 2026-2031
3.3 Global EPA DHA ALA (Omega 3) Revenue by Region: 2020-2031
3.3.1 Global EPA DHA ALA (Omega 3) Revenue by Region: 2020-2025
3.3.2 Global EPA DHA ALA (Omega 3) Revenue by Region: 2026-2031
3.4 North America EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.4.1 North America EPA DHA ALA (Omega 3) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America EPA DHA ALA (Omega 3) Sales by Country (2020-2031)
3.4.3 North America EPA DHA ALA (Omega 3) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.5.1 Europe EPA DHA ALA (Omega 3) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe EPA DHA ALA (Omega 3) Sales by Country (2020-2031)
3.5.3 Europe EPA DHA ALA (Omega 3) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific EPA DHA ALA (Omega 3) Market Facts & Figures by Region
3.6.1 Asia Pacific EPA DHA ALA (Omega 3) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific EPA DHA ALA (Omega 3) Sales by Region (2020-2031)
3.6.3 Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.7.1 Latin America EPA DHA ALA (Omega 3) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America EPA DHA ALA (Omega 3) Sales by Country (2020-2031)
3.7.3 Latin America EPA DHA ALA (Omega 3) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.8.1 Middle East and Africa EPA DHA ALA (Omega 3) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2020-2031)
3.8.3 Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global EPA DHA ALA (Omega 3) Sales by Type (2020-2031)
4.1.1 Global EPA DHA ALA (Omega 3) Sales by Type (2020-2025)
4.1.2 Global EPA DHA ALA (Omega 3) Sales by Type (2026-2031)
4.1.3 Global EPA DHA ALA (Omega 3) Sales Market Share by Type (2020-2031)
4.2 Global EPA DHA ALA (Omega 3) Revenue by Type (2020-2031)
4.2.1 Global EPA DHA ALA (Omega 3) Revenue by Type (2020-2025)
4.2.2 Global EPA DHA ALA (Omega 3) Revenue by Type (2026-2031)
4.2.3 Global EPA DHA ALA (Omega 3) Revenue Market Share by Type (2020-2031)
4.3 Global EPA DHA ALA (Omega 3) Price by Type (2020-2031)
5 Segment by Application
5.1 Global EPA DHA ALA (Omega 3) Sales by Application (2020-2031)
5.1.1 Global EPA DHA ALA (Omega 3) Sales by Application (2020-2025)
5.1.2 Global EPA DHA ALA (Omega 3) Sales by Application (2026-2031)
5.1.3 Global EPA DHA ALA (Omega 3) Sales Market Share by Application (2020-2031)
5.2 Global EPA DHA ALA (Omega 3) Revenue by Application (2020-2031)
5.2.1 Global EPA DHA ALA (Omega 3) Revenue by Application (2020-2025)
5.2.2 Global EPA DHA ALA (Omega 3) Revenue by Application (2026-2031)
5.2.3 Global EPA DHA ALA (Omega 3) Revenue Market Share by Application (2020-2031)
5.3 Global EPA DHA ALA (Omega 3) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 EPAX
6.1.1 EPAX Company Information
6.1.2 EPAX Description and Business Overview
6.1.3 EPAX EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 EPAX EPA DHA ALA (Omega 3) Product Portfolio
6.1.5 EPAX Recent Developments/Updates
6.2 Golden Omega
6.2.1 Golden Omega Company Information
6.2.2 Golden Omega Description and Business Overview
6.2.3 Golden Omega EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Golden Omega EPA DHA ALA (Omega 3) Product Portfolio
6.2.5 Golden Omega Recent Developments/Updates
6.3 TASA
6.3.1 TASA Company Information
6.3.2 TASA Description and Business Overview
6.3.3 TASA EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TASA EPA DHA ALA (Omega 3) Product Portfolio
6.3.5 TASA Recent Developments/Updates
6.4 Omega Protein
6.4.1 Omega Protein Company Information
6.4.2 Omega Protein Description and Business Overview
6.4.3 Omega Protein EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Omega Protein EPA DHA ALA (Omega 3) Product Portfolio
6.4.5 Omega Protein Recent Developments/Updates
6.5 Croda
6.5.1 Croda Company Information
6.5.2 Croda Description and Business Overview
6.5.3 Croda EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Croda EPA DHA ALA (Omega 3) Product Portfolio
6.5.5 Croda Recent Developments/Updates
6.6 KD Pharma
6.6.1 KD Pharma Company Information
6.6.2 KD Pharma Description and Business Overview
6.6.3 KD Pharma EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 KD Pharma EPA DHA ALA (Omega 3) Product Portfolio
6.6.5 KD Pharma Recent Developments/Updates
6.7 GC Rieber
6.7.1 GC Rieber Company Information
6.7.2 GC Rieber Description and Business Overview
6.7.3 GC Rieber EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GC Rieber EPA DHA ALA (Omega 3) Product Portfolio
6.7.5 GC Rieber Recent Developments/Updates
6.8 Polaris
6.8.1 Polaris Company Information
6.8.2 Polaris Description and Business Overview
6.8.3 Polaris EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Polaris EPA DHA ALA (Omega 3) Product Portfolio
6.8.5 Polaris Recent Developments/Updates
6.9 Auqi
6.9.1 Auqi Company Information
6.9.2 Auqi Description and Business Overview
6.9.3 Auqi EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Auqi EPA DHA ALA (Omega 3) Product Portfolio
6.9.5 Auqi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 EPA DHA ALA (Omega 3) Industry Chain Analysis
7.2 EPA DHA ALA (Omega 3) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 EPA DHA ALA (Omega 3) Production Mode & Process Analysis
7.4 EPA DHA ALA (Omega 3) Sales and Marketing
7.4.1 EPA DHA ALA (Omega 3) Sales Channels
7.4.2 EPA DHA ALA (Omega 3) Distributors
7.5 EPA DHA ALA (Omega 3) Customer Analysis
8 EPA DHA ALA (Omega 3) Market Dynamics
8.1 EPA DHA ALA (Omega 3) Industry Trends
8.2 EPA DHA ALA (Omega 3) Market Drivers
8.3 EPA DHA ALA (Omega 3) Market Challenges
8.4 EPA DHA ALA (Omega 3) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global EPA DHA ALA (Omega 3) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global EPA DHA ALA (Omega 3) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global EPA DHA ALA (Omega 3) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global EPA DHA ALA (Omega 3) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global EPA DHA ALA (Omega 3) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global EPA DHA ALA (Omega 3) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global EPA DHA ALA (Omega 3) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market EPA DHA ALA (Omega 3) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of EPA DHA ALA (Omega 3), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of EPA DHA ALA (Omega 3), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of EPA DHA ALA (Omega 3), Product Type & Application
 Table 12. Global Key Manufacturers of EPA DHA ALA (Omega 3), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global EPA DHA ALA (Omega 3) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EPA DHA ALA (Omega 3) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global EPA DHA ALA (Omega 3) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global EPA DHA ALA (Omega 3) Sales by Region (2020-2025) & (K Units)
 Table 18. Global EPA DHA ALA (Omega 3) Sales Market Share by Region (2020-2025)
 Table 19. Global EPA DHA ALA (Omega 3) Sales by Region (2026-2031) & (K Units)
 Table 20. Global EPA DHA ALA (Omega 3) Sales Market Share by Region (2026-2031)
 Table 21. Global EPA DHA ALA (Omega 3) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global EPA DHA ALA (Omega 3) Revenue Market Share by Region (2020-2025)
 Table 23. Global EPA DHA ALA (Omega 3) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global EPA DHA ALA (Omega 3) Revenue Market Share by Region (2026-2031)
 Table 25. North America EPA DHA ALA (Omega 3) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America EPA DHA ALA (Omega 3) Sales by Country (2020-2025) & (K Units)
 Table 27. North America EPA DHA ALA (Omega 3) Sales by Country (2026-2031) & (K Units)
 Table 28. North America EPA DHA ALA (Omega 3) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America EPA DHA ALA (Omega 3) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe EPA DHA ALA (Omega 3) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe EPA DHA ALA (Omega 3) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe EPA DHA ALA (Omega 3) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe EPA DHA ALA (Omega 3) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe EPA DHA ALA (Omega 3) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific EPA DHA ALA (Omega 3) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific EPA DHA ALA (Omega 3) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America EPA DHA ALA (Omega 3) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America EPA DHA ALA (Omega 3) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America EPA DHA ALA (Omega 3) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America EPA DHA ALA (Omega 3) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America EPA DHA ALA (Omega 3) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global EPA DHA ALA (Omega 3) Sales (K Units) by Type (2020-2025)
 Table 51. Global EPA DHA ALA (Omega 3) Sales (K Units) by Type (2026-2031)
 Table 52. Global EPA DHA ALA (Omega 3) Sales Market Share by Type (2020-2025)
 Table 53. Global EPA DHA ALA (Omega 3) Sales Market Share by Type (2026-2031)
 Table 54. Global EPA DHA ALA (Omega 3) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global EPA DHA ALA (Omega 3) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global EPA DHA ALA (Omega 3) Revenue Market Share by Type (2020-2025)
 Table 57. Global EPA DHA ALA (Omega 3) Revenue Market Share by Type (2026-2031)
 Table 58. Global EPA DHA ALA (Omega 3) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global EPA DHA ALA (Omega 3) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global EPA DHA ALA (Omega 3) Sales (K Units) by Application (2020-2025)
 Table 61. Global EPA DHA ALA (Omega 3) Sales (K Units) by Application (2026-2031)
 Table 62. Global EPA DHA ALA (Omega 3) Sales Market Share by Application (2020-2025)
 Table 63. Global EPA DHA ALA (Omega 3) Sales Market Share by Application (2026-2031)
 Table 64. Global EPA DHA ALA (Omega 3) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global EPA DHA ALA (Omega 3) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global EPA DHA ALA (Omega 3) Revenue Market Share by Application (2020-2025)
 Table 67. Global EPA DHA ALA (Omega 3) Revenue Market Share by Application (2026-2031)
 Table 68. Global EPA DHA ALA (Omega 3) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global EPA DHA ALA (Omega 3) Price (US$/Unit) by Application (2026-2031)
 Table 70. EPAX Company Information
 Table 71. EPAX Description and Business Overview
 Table 72. EPAX EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. EPAX EPA DHA ALA (Omega 3) Product
 Table 74. EPAX Recent Developments/Updates
 Table 75. Golden Omega Company Information
 Table 76. Golden Omega Description and Business Overview
 Table 77. Golden Omega EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Golden Omega EPA DHA ALA (Omega 3) Product
 Table 79. Golden Omega Recent Developments/Updates
 Table 80. TASA Company Information
 Table 81. TASA Description and Business Overview
 Table 82. TASA EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TASA EPA DHA ALA (Omega 3) Product
 Table 84. TASA Recent Developments/Updates
 Table 85. Omega Protein Company Information
 Table 86. Omega Protein Description and Business Overview
 Table 87. Omega Protein EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Omega Protein EPA DHA ALA (Omega 3) Product
 Table 89. Omega Protein Recent Developments/Updates
 Table 90. Croda Company Information
 Table 91. Croda Description and Business Overview
 Table 92. Croda EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Croda EPA DHA ALA (Omega 3) Product
 Table 94. Croda Recent Developments/Updates
 Table 95. KD Pharma Company Information
 Table 96. KD Pharma Description and Business Overview
 Table 97. KD Pharma EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. KD Pharma EPA DHA ALA (Omega 3) Product
 Table 99. KD Pharma Recent Developments/Updates
 Table 100. GC Rieber Company Information
 Table 101. GC Rieber Description and Business Overview
 Table 102. GC Rieber EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GC Rieber EPA DHA ALA (Omega 3) Product
 Table 104. GC Rieber Recent Developments/Updates
 Table 105. Polaris Company Information
 Table 106. Polaris Description and Business Overview
 Table 107. Polaris EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Polaris EPA DHA ALA (Omega 3) Product
 Table 109. Polaris Recent Developments/Updates
 Table 110. Auqi Company Information
 Table 111. Auqi Description and Business Overview
 Table 112. Auqi EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Auqi EPA DHA ALA (Omega 3) Product
 Table 114. Auqi Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. EPA DHA ALA (Omega 3) Distributors List
 Table 118. EPA DHA ALA (Omega 3) Customers List
 Table 119. EPA DHA ALA (Omega 3) Market Trends
 Table 120. EPA DHA ALA (Omega 3) Market Drivers
 Table 121. EPA DHA ALA (Omega 3) Market Challenges
 Table 122. EPA DHA ALA (Omega 3) Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of EPA DHA ALA (Omega 3)
 Figure 2. Global EPA DHA ALA (Omega 3) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global EPA DHA ALA (Omega 3) Market Share by Type: 2024 & 2031
 Figure 4. Fish Oil Product Picture
 Figure 5. Algae Oil Product Picture
 Figure 6. Global EPA DHA ALA (Omega 3) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global EPA DHA ALA (Omega 3) Market Share by Application: 2024 & 2031
 Figure 8. Dietary Supplements
 Figure 9. Functional Foods & Beverages
 Figure 10. Others
 Figure 11. Global EPA DHA ALA (Omega 3) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global EPA DHA ALA (Omega 3) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global EPA DHA ALA (Omega 3) Sales (2020-2031) & (K Units)
 Figure 14. Global EPA DHA ALA (Omega 3) Average Price (US$/Unit) & (2020-2031)
 Figure 15. EPA DHA ALA (Omega 3) Report Years Considered
 Figure 16. EPA DHA ALA (Omega 3) Sales Share by Manufacturers in 2024
 Figure 17. Global EPA DHA ALA (Omega 3) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest EPA DHA ALA (Omega 3) Players: Market Share by Revenue in EPA DHA ALA (Omega 3) in 2024
 Figure 19. EPA DHA ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global EPA DHA ALA (Omega 3) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America EPA DHA ALA (Omega 3) Sales Market Share by Country (2020-2031)
 Figure 22. North America EPA DHA ALA (Omega 3) Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe EPA DHA ALA (Omega 3) Sales Market Share by Country (2020-2031)
 Figure 26. Europe EPA DHA ALA (Omega 3) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific EPA DHA ALA (Omega 3) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific EPA DHA ALA (Omega 3) Revenue Market Share by Region (2020-2031)
 Figure 34. China EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America EPA DHA ALA (Omega 3) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America EPA DHA ALA (Omega 3) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa EPA DHA ALA (Omega 3) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa EPA DHA ALA (Omega 3) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE EPA DHA ALA (Omega 3) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of EPA DHA ALA (Omega 3) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of EPA DHA ALA (Omega 3) by Type (2020-2031)
 Figure 56. Global EPA DHA ALA (Omega 3) Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of EPA DHA ALA (Omega 3) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of EPA DHA ALA (Omega 3) by Application (2020-2031)
 Figure 59. Global EPA DHA ALA (Omega 3) Price (US$/Unit) by Application (2020-2031)
 Figure 60. EPA DHA ALA (Omega 3) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI